Paz-Ibarra, J., Lu-Antara, J., Uscamayta, B., Martinez-Auris, J., Valencia-Rivera, M., Sáenz-Bustamante, S., . . . Concepción-Zavaleta, M. (2023). Imatinib use in the management of a patient with Doege–Potter syndrome.
Citación estilo ChicagoPaz-Ibarra, Jose, Jose Lu-Antara, Brenda-Erendida Uscamayta, Jhancy Martinez-Auris, Miriam Valencia-Rivera, Sofía Sáenz-Bustamante, Marialejandra Delgado-Rojas, Julia Salcedo-Vasquez, y Marcio Concepción-Zavaleta. Imatinib Use in the Management of a Patient With Doege–Potter Syndrome. 2023.
Cita MLAPaz-Ibarra, Jose, et al. Imatinib Use in the Management of a Patient With Doege–Potter Syndrome. 2023.